Pharmacological analysis of 5-HT-receptor-mediated vasoconstriction of human middle meningeal arteries: Determining the contribution of 5-HT1B and 5-HT1F receptor activation

被引:0
|
作者
Razzaque, Z
Shaw, D
Smith, D
Hopkins, R
Sirinathsinghji, D
Maskell, L
Stanton, JA
Beer, MS
Hill, RG
Pickard, J
Longmore, J
机构
[1] MERCK SHARP & DOHME LTD,NEUROSCI RES CTR,RES LABS,HARLOW CM20 2QR,ESSEX,ENGLAND
[2] ADDENBROOKES HOSP,NEUROSURG UNIT,CAMBRIDGE CB2 2QQ,ENGLAND
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:P211 / P211
页数:1
相关论文
共 50 条
  • [41] Reduction of the serotonin 5-HT1B and 5-HT2A receptor-mediated contraction of human pulmonary artery by the combined 5-HT1B receptor antagonist and serotonin transporter inhibitor LY393558
    Baranowska-Kuczko, Marta
    Kozlowska, Hanna
    Schlicker, Eberhard
    Gothert, Manfred
    MacLean, Margaret R.
    Kozlowski, Miroslaw
    Kloza, Monika
    Sadowska, Olga
    Malinowska, Barbara
    PHARMACOLOGICAL REPORTS, 2020, 72 (03) : 756 - 762
  • [42] CONSTRICTION OF PORCINE ARTERIOVENOUS ANASTOMOSES BY INDORENATE IS UNRELATED TO 5-HT1A, 5-HT1B, 5-HT1C OR 5-HT1D RECEPTOR SUBTYPES
    VILLALON, CM
    BOM, AH
    HEILIGERS, JPC
    DENBOER, MO
    SAXENA, PR
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 190 (1-2) : 167 - 176
  • [43] Juvenile 5HT1B receptor knockout mice exhibit reduced pharmacological sensitivity to 5HT1A receptor activation
    El-Khodor, BF
    Dimmler, MH
    Amara, DA
    Hofer, M
    Hen, R
    Brunner, D
    INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2004, 22 (5-6) : 405 - 413
  • [44] 5-HT1A receptor sensitivity in 5-HT1B receptor KO mice is unaffected by chronic fluvoxamine treatment
    Vinkers, Christiaan H.
    Groenink, Lucianne
    Pattij, Tommy
    Olivier, Berend
    Bouwknecht, J. Adriaan
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 667 (1-3) : 250 - 257
  • [45] The effects of 5-HT1A, 5-HT1B and 5-HT1D receptor agonists on trigeminal nociceptive neurotransmission in anaesthetized rats
    Cumberbatch, MJ
    Hill, RG
    Hargreaves, RJ
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 362 (01) : 43 - 46
  • [46] Serotonin (5-HT) Activation of Immortalized Hypothalamic Neuronal Cells Through the 5-HT1B Serotonin Receptor
    Tung, Stephanie
    Hardy, Alexandre B.
    Wheeler, Michael B.
    Belsham, Denise D.
    ENDOCRINOLOGY, 2012, 153 (10) : 4862 - 4873
  • [47] Effect of reserpine on behavioural responses to agonists at 5-HT1A, 5-HT1B, 5-HT2A, and 5-HT2C receptor subtypes
    Heslop, KE
    Curzon, G
    NEUROPHARMACOLOGY, 1999, 38 (06) : 883 - 891
  • [48] Augmentation with a 5-HT1A but not a 5-HT1B receptor antagonist critically depends on the dose of citalopram
    Cremers, TIFH
    de Boer, P
    Liao, Y
    Bosker, FJ
    den Boer, JA
    Westerink, BHC
    Wikström, HV
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 397 (01) : 63 - 74
  • [49] Exclusion of 5-HT1B and 5-HT1D serotonin receptor genes in migraine.
    Marttila, P
    Kallela, M
    Wessman, M
    Hartiala, J
    Färkkilä, M
    Kaprio, J
    Peltonen, L
    Palotie, A
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A460 - A460
  • [50] Hypothermia and the 5-HT syndrome induced by CGS 12066B independently of 5-HT1B receptor activation
    Bjorvatn, B
    Neckelmann, D
    Bjorkum, AA
    Ursin, R
    BEHAVIOURAL PHARMACOLOGY, 1996, 7 (05): : 462 - 469